Holmusk

Holmusk

Private
New York City, New YorkHealthcare & Life Scienceshttps://holmusk.com

Last Round

Series B

Extension

Oct 2, 2023

Total Funding Raised

$106.25M

Company Overview

Holmusk is a health technology company that provides a data analytics platform to transform research and care for behavioral health.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Mental Health, Medical AI, EHR & EMR, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

real-world evidenceRWEbehavioral health datamental health techreal-world dataRWDhealthcare analyticsnatural language processingNLPpredictive analyticsclinical intelligencepharma techEHR datadrug developmentelectronic health recordEHRvalue-based caredata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Holmusk Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Holmusk Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionOct 2, 2023
Series BJan 9, 2023
Series A ExtensionDec 6, 2021
Series AMay 18, 2020
SeedSep 25, 2018

Key People

Founding team and executive leadership

Nawal Roy

Founder & CEO

Founding Team

Tony Tramontin

President And COO

Executive Team

Padmagirisan Subramanian

Chief Technology Officer

Executive Team

Holmusk Investors

Notable investors and investment history

InvestorRounds
dRx CapitalSeries B, Series A Extension
Heritas Capital ManagementSeries A Extension, Series B, Seed, Series A
Singapore Health ManagementSeries A
Health Catalyst Capital ManagementSeries B, Series A Extension, Series A
NTAssetSeed
Optum VenturesSeries A, Series A Extension
Northwell HoldingsSeries B, Series A Extension

Holmusk Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Holmusk Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Holmusk's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range92
Year Founded2015
Last FundingOct 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.